The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Unattributed | Alive

Total Raised


Last Raised

$250K | 8 yrs ago

About Biomimedica

Biomimedica is developing earlier intervention solutions to treat osteoarthritis that will allow patients to maintain a pain-free, active lifestyle.

Biomimedica Headquarter Location

9470 Johnson Road Ext

Germantown, Tennessee, 38139,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Biomimedica Patents

Biomimedica has filed 5 patents.

patents chart

Application Date

Grant Date


Related Topics




Skeletal system, Prosthetics, Implants (medicine), Orthopedic surgical procedures, Bones of the head and neck


Application Date


Grant Date



Related Topics

Skeletal system, Prosthetics, Implants (medicine), Orthopedic surgical procedures, Bones of the head and neck



Latest Biomimedica News

Global Arthroscopy Market Analysis 2016 - Forecast to 2022 - Key Vendors are Active Implants, Biomimedica & OrthoSpace - Research and Markets

Dec 13, 2016

Global Arthroscopy Market Analysis 2016 - Forecast to 2022 - Key Vendors are Active Implants, Biomimedica & OrthoSpace - Research and Markets December 13, 2016 11:23 AM Eastern Standard Time DUBLIN--( BUSINESS WIRE )--Research and Markets has announced the addition of the "Global Arthroscopy Market Analysis 2016 - Forecast to 2022" report to their offering. This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides: Market Sizing estimations and forecasts for 6 years across the given market segments. Identifying market dynamics. Strategic recommendations in key business segments based on the market estimations. Regional and country level market analysis. Competitive landscaping of major market players. Company profiling covering the financials, recent activities and the future strategies. Companies Mentioned:

  • When was Biomimedica founded?

    Biomimedica was founded in 2008.

  • Where is Biomimedica's headquarters?

    Biomimedica's headquarters is located at 9470 Johnson Road Ext, Germantown.

  • What is Biomimedica's latest funding round?

    Biomimedica's latest funding round is Unattributed.

  • How much did Biomimedica raise?

    Biomimedica raised a total of $17.37M.

  • Who are the investors of Biomimedica?

    Investors of Biomimedica include Asset Management Ventures, Emergent Medical Partners, Troika Ventures, Biedermann Motech, Silicon Valley Greek Seed Fund and 4 more.

  • Who are Biomimedica's competitors?

    Competitors of Biomimedica include PartsSource, Wright Medical Group, Cagenix, ArthroSurface, Avedro, BioSet, Ocular Therapeutix, Orthovita, Osteotech, Facet Solutions and 13 more.

You May Also Like


OrthoMimetics aiming to bring to market a line of products for the regenerative repair of cartilage, ligament and tendon injuries.

Serica Technologies

Serica is a medical device company focused on the development of silk-based biomaterial platforms that may be used in tissue repair. The company's approach leverages natural silk in combination with advances in biomedical engineering to address needs in the repair of damaged connective tissue, caused by disease, trauma, or aging. Serica's products are being studied for use in orthopaedics and sports medicine, aesthetic and reconstructive plastic surgery, and multiple additional structural tissue repair applications.


Haemechanics has developed a synthetic, hemostatic material capable of simultaneously inducing blood clotting and delivering therapeutics. The material is able to induce clotting as effectively as biologically based products, at a fraction of the price.

SpineAlign Medical

Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.

TransCorp Logo

TransCorp develops and commercializes minimally invasive surgical instruments and implants for neurosurgical and orthopedic applications.

Noxilizer Logo

Noxilizer has a unique room temperature NO2-based sterilization technology that is changing two major sterilization markets - medical device/pharmaceutical/biotechnology manufacturing and hospitals. In the manufacturing market, Noxilizer provides sterilization services for medical devices and drug/device combination products. Noxilizer sells the RTS 360 Industrial NO2 Sterilizer to companies who sterilize products in-house and also offers contract sterilization services. In hospitals, Noxilizer is developing a system especially for sensitive, high-tech equipment used in minimally-invasive surgical procedures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.